Short Interest in MariMed Inc. (OTCMKTS:MRMD) Expands By 108.6%

MariMed Inc. (OTCMKTS:MRMD) was the recipient of a large increase in short interest during the month of July. As of July 15th, there was short interest totaling 3,893 shares, an increase of 108.6% from the June 30th total of 1,866 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 548,629 shares, the days-to-cover ratio is presently 0.0 days.

MariMed Price Performance

MRMD opened at $0.06 on Friday. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.34 and a current ratio of 0.95. The stock has a market capitalization of $25.51 million, a PE ratio of -2.12 and a beta of 1.32. The stock’s 50 day moving average price is $0.07 and its 200-day moving average price is $0.08. MariMed has a 52-week low of $0.06 and a 52-week high of $0.23.

MariMed (OTCMKTS:MRMD) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). The company had revenue of $39.48 million during the quarter, compared to analyst estimates of $38.75 million. MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.